- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Pharmadrug Inc (2): Pharmadrug puts itself on the block | 1 | Stockwatch | ||
| Fr | PharmaDrug Inc.: PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value | 215 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 15.11.24 | PharmaDrug Inc.: PharmaDrug Announces Issuance of Debenture Units | 828 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 15, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 31.10.24 | PharmaDrug Inc.: PharmaDrug Announces Proposed Issuance of Debenture Units | 486 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 31.10.24 | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases | 361 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| PHARMADRUG Aktie jetzt für 0€ handeln | |||||
| 19.09.24 | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases | 337 | Newsfile | Toronto, Ontario--(Newsfile Corp. - September 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research,... ► Artikel lesen | |
| 28.08.24 | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases | 535 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 21.08.24 | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins | 551 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 21, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 19.08.24 | PharmaDrug Inc.: PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine | 556 | Newsfile | Toronto, Ontario--(Newsfile Corp. - August 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 5,030 | +0,20 % | Aurora Cannabis Inc (3): Aurora Cannabis launches IndiMed Tempo 22 | ||
| CANOPY GROWTH | 1,498 | +0,67 % | Canopy Growth has price target chopped at Roth | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 0,357 | +0,11 % | Tilray Brands Inc: Tilray Brands to be deleted from S&P/TSX Composite | ||
| INNOCAN PHARMA | 0,111 | +2,31 % | Unglaubliche Prognose für Montag setzt Innocan Pharma Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT clarifies disclosure about Premium Products buy | ||
| DERMAPHARM | 36,900 | -0,40 % | EQS-DD: Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
04.06.2025 / 11:18... ► Artikel lesen | |
| CRONOS GROUP | 1,728 | -0,80 % | Cronos Group Inc.: Cronos Group Reports 2025 First Quarter Results | Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in... ► Artikel lesen | |
| SYNBIOTIC | 3,120 | -2,50 % | EQS-DD: SYNBIOTIC SE: HempConsult GmbH, Verleih (unentgeltlich) von 50.000 Aktien im Rahmen einer Wertpapierleihe. | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
23.04.2025 / 09:22... ► Artikel lesen | |
| VIATRIS | 7,584 | -0,73 % | Viatris Reports Positive Top-line Results From LYNX-2 Phase 3 Trial With MR-142 | WASHINGTON (dpa-AFX) - Viatris (VTRS) reported positive top-line results from LYNX-2, a Phase 3 trial evaluating MR-142 in treating significant, chronic night driving impairment in keratorefractive... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,170 | -1,68 % | Organigram Global Inc. reicht 6-K Bericht bei der SEC ein | ||
| SNDL | 1,147 | -0,61 % | SNDL Inc.: SNDL Reports First Quarter 2025 Financial and Operational Results | The Company Delivers Record Gross Margin and Positive Cash Flow; Announces Strategic Review of U.S. Platform and Listing Structure
EDMONTON, AB, May 1, 2025 ... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 4,600 | +0,97 % | Green Thumb Industries Inc: Green Thumb to hold cannabis, music festival | ||
| CRESCO LABS | 0,496 | +1,85 % | Canaccord Genuity stuft Cresco Labs-Aktie aufgrund von Wettbewerbsdruck herab |
PHARMADRUG INC gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMADRUG INC finden Sie auf Wallstreet Online.